Courtney Thorne

Courtney’s practice focuses on the representation of public companies and investment banks in the life sciences industry – with an emphasis on capital raising, public company counseling, foreign private issuer matters and securities law compliance. In addition to a robust US practice, she also has substantial experience advising non-US companies, known as foreign private issuers (FPIs), seeking to access the US capital markets or list on a US securities exchange.

Courtney regularly acts as primary outside counsel for a number of publicly traded clients, advising companies and their boards of directors with respect to SEC periodic reporting and disclosure obligations, strategic corporate decisions, annual meeting and proxy-related issues, beneficial ownership reporting, securities exchange listing standards, corporate governance, and Sarbanes-Oxley Act compliance, as well as other general corporate and securities matters.

Courtney also represents domestic and foreign issuers, investment banks and financial institutions in connection with initial and follow-on public offerings, shelf registrations and shelf takedown offerings, Regulation S offerings, registered direct offerings, at-the-market (ATM) offerings, private investments in public equity (PIPEs), and private placements of equity and debt securities by life sciences companies.